CEO: John G. McHutchison

Sector: Health Technology

Exchange: NASDAQ

Country: US

Description: Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.


Key numbers

Market Capitalization:720874472
Shares Outstanding: 32722400
Float: 30516616
Next Earning Date:2020-08-05
TTm EPS: -3.4333
TTm Dividend Rate:
200 days moving average:18.54
50 days moving average: 22.31
One day percent Change: -0.8



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,